• Robert Alongi

CDC and FDA Issue Statement on Johnson & Johnson Vaccine

Dear Pharmacists,

As of April 13th, the FDA and CDC issued a joint statement regarding the Johnson & Johnson vaccine. There have been 6 reported cases of blood clots occurring in women aged 18-48 within 1-2 weeks after vaccination. Both the FDA and CDC recommend a hold in administering the vaccine for precautionary reasons "to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot."

If a patient has received the Johnson & Johnson vaccine and experiences severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, they should contact their healthcare provider.

For more information:

5 views0 comments

Recent Posts

See All

Medicare Open Enrollment Begins Today!

Open enrollment for Medicare health and drug plans began today! Now is a wonderful opportunity to encourage your patients who are currently enrolled in Medicare Advantage and/or prescription drug plan

COVID-19 Booster Billing Codes Issued

The National Community Pharmacists Association (NCPA) has updated its COVID-19 vaccine billing and reimbursement handout to reflect the changes in the National Council for Prescription Drug Programs'